News | The Australasian Leukaemia and Lymphoma Group

Below you’ll find the ALLG’s latest news announcements.

Six new Optimal Care Pathways released for blood cancer treatment and care

ALLG trials BM12, CML12 and LS21 accepted to European Hematology Association (EHA) 2022

ALLG Member, haematologist Professor Tim Hughes appointed to Academy of Science

$2.8m MRFF boost for vital cancer immunotherapy research – expanding Australia’s trial capacity of a front-line study of a rare blood cancer

Vale Associate Professor James D’Rozario

World Cancer Day Feb 4

ALLG Member, haematologist and clinical researcher awarded AM for service to the blood cancer community

ALLG and HSANZ Welcome the House of Representatives’ Standing Committee Report tabled in Parliament 25 November 2021